Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Tianxiao Liu, Songyuan Luo, Peter Libby, Guo‐Ping Shi
Topics & Concepts
CoronavirusVirologyMiddle East respiratory syndrome coronavirusHydroxychloroquineBiologyCathepsin LEbola virusPopulationVirusLipid bilayer fusionMedicineCathepsinCoronavirus disease 2019 (COVID-19)EnzymeInfectious disease (medical specialty)BiochemistryDiseaseEnvironmental healthPathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies